What do systematic reviews say?

Biotin vs placebo

The review found no eligible studies for this question.

• Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Proprietary products vs placebo

The review found no eligible studies for this question.

• Interventions for infantile seborrhoeic dermatitis (including cradle cap) 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antibiotic prophylaxis vs no treatment/placebo

The review found no eligible studies for this question.

• Interventions for the prevention of recurrent erysipelas and cellulitis 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Complete cure and adverse events for terbinafine vs placebo

The review found no eligible studies for this question.

• Oral antifungal medication for toenail onychomycosis 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Azoles vs placebo

The review found no eligible studies for this question.

• Oral antifungal medication for toenail onychomycosis 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Chemical peeling vs placebo or no treatment

The review found no eligible studies for this question.

• Interventions for acne scars 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Injectable fillers vs placebo or no treatment

The review found no eligible studies for this question.

• Interventions for acne scars 2016 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

FAE vs placebo

• Oral fumaric acid esters for psoriasis 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 175 participants
  Low

R‐salbutamol 0.5% topical cream vs placebo

The review found no eligible studies for this question.

• Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Tacrolimus 0.1% cream vs placebo

The review found no eligible studies for this question.

• Drugs for discoid lupus erythematosus 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Minoxidil vs placebo

• Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 260 participants
  Low

Serlopitant 0.25 mg vs placebo

• Interventions for chronic pruritus of unknown origin 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 127 participants
  Very low

Serlopitant 5 mg vs placebo

• Interventions for chronic pruritus of unknown origin 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 127 participants
  Very low

Serlopitant 1 mg vs placebo

• Interventions for chronic pruritus of unknown origin 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 128 participants
  Very low

Montelukast vs placebo

The review found no eligible studies for this question.

• Leukotriene receptor antagonists for eczema 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Etanercept vs placebo

• Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 17 participants
  Moderate

Summary of findings table ‐ Oral classical immunosuppressants (prednisolone or cyclosporine) vs placebo

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 36 participants
  Very low

Finasteride vs placebo

• Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Summary of findings table ‐ Intralesional classical immunosuppresants (betamethasone or triamcinolone) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found